Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Taurolithocholic acid (TLCA) is a taurine-conjugated form of the secondary bile acid lithocholic acid (Item No. 20253).1 TLCA (75 μM) increases caspase-3 and -7 activity in Hep3B cells transfected with sodium taurocholate cotransporting peptide (NTCP), but not nontransfected Hep3B cells.2 It has been used to induce cholestasis in ex vivo and in vivo animal models of hepatocellular cholestasis.3,4 Serum levels of TLCA increase approximately 5-fold in within two hours during an oral lipid tolerance test in humans.1
WARNING This product is not for human or veterinary use.
1. Bile acid metabolome after an oral lipid tolerance test by liquid chromatography-
2. Bile acid-
3. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-
4. Cholestasis in rats induced by taurolithocholate. Nature 210(5042), 1262-1263 (1966).
PTER is a N-